Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dementia without cholinergic deficit.

P J Riekkinen1, H Soininen, J Sirviö

  • 1Department of Neurology, University of Kuopio, Finland.

Gerontology
|January 1, 1987
PubMed
Summary

Multi-infarct dementia (MID) patients show normal acetylcholinesterase (AChE) levels, unlike Alzheimer's disease (AD) patients who have reduced AChE. Severe dementia can occur without cholinergic system dysfunction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined Evidence for a Long-Term, Clinical Slowing Effect of Multinutrient Intervention in Prodromal Alzheimer's Disease: Post-Hoc Analysis of 3-Year Data from the LipiDiDiet Trial.

The journal of prevention of Alzheimer's disease·2023
Same author

Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress.

The journal of prevention of Alzheimer's disease·2022
Same author

5-Year health-related quality of life outcome in patients with idiopathic normal pressure hydrocephalus.

Journal of neurology·2021
Same author

Midlife improvements in financial situation are associated with a reduced dementia risk later in life: the CAIDE 30-year study.

International psychogeriatrics·2019
Same author

Alzheimer's Disease Composite Score: A Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease.

The journal of prevention of Alzheimer's disease·2019
Same author

Brain β-Amyloid and Atrophy in Individuals at Increased Risk of Cognitive Decline.

AJNR. American journal of neuroradiology·2018

Area of Science:

  • Neuroscience
  • Neurology
  • Biochemistry

Background:

  • The cholinergic system plays a crucial role in cognitive functions.
  • Cholinergic deficits are commonly associated with dementia, particularly Alzheimer's disease (AD).
  • The involvement of the cholinergic system in multi-infarct dementia (MID) remains less understood.

Purpose of the Study:

  • To investigate the role of the cholinergic system in multi-infarct dementia (MID).
  • To compare acetylcholinesterase (AChE) levels in cerebrospinal fluid (CSF) between MID patients, AD patients, and controls.
  • To analyze choline acetyltransferase (ChAT) levels in cortical brain areas of AD patients, non-AD demented patients, and controls.

Main Methods:

  • Measurement of acetylcholinesterase (AChE) activities in CSF from clinically diagnosed MID, AD patients, and controls.

Related Experiment Videos

  • Analysis of choline acetyltransferase (ChAT) levels in four cortical brain areas from autopsy studies of AD, non-AD dementia, and control groups.

    • Main Results:

    • MID patients exhibited unaltered AChE levels in CSF compared to controls, despite similar dementia severity.
    • AD patients demonstrated significantly reduced AChE levels in CSF.
    • Autopsy studies revealed a marked loss of ChAT activity in all studied cortical areas in AD patients, while non-AD patients showed levels similar to controls.

    Conclusions:

    • Severe dementia, as seen in MID, can manifest without significant cholinergic dysfunction.
    • The findings differentiate the neurochemical profiles of MID and AD, highlighting distinct pathophysiological mechanisms.
    • Cholinergic deficit is not a universal hallmark of all forms of severe dementia.